Concepedia

Stéphanie Filleur

SF

Statistics

Publications

28

Citations

2.5K

H-Index

21

Active since

1999

Affiliations

Texas Tech University(Current)

Texas Tech University Health Sciences Center

Otto-von-Guericke-Universität Magdeburg

Northwestern University

Centre National de la Recherche Scientifique

Stéphanie Filleur is an author at Texas Tech University specializing in medicine, oncology, and prostate cancer.

ORCID

Publications per year

1999–2020

28

Publications

28

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

Pierrick G.J. Fournier, Stéphanie Filleur, Julien Guglielmi et al. · PubMed · 2002 · 571 citations

, , +15

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche

Michael P. Plebanek, Nicholas L. Angeloni, Elena Vinokour et al. · Nature Communications · 2017 · 284 citations · Full text

, , +17

SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.

Stéphanie Filleur, Aurélie Courtin, Slimane Ait‐Si‐Ali et al. · PubMed · 2003 · 254 citations

, , +17

Two Functional Epitopes of Pigment Epithelial–Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer

Stéphanie Filleur, Karl Volz, Thomas Nelius et al. · Cancer Research · 2005 · 164 citations · Full text

, , +15

CBP/p300 histone acetyl-transferase activity is important for the G1/S transition

Slimane Ait‐Si‐Ali, Anna Polesskaya, Stéphanie Filleur et al. · Oncogene · 2000 · 141 citations

, , +16

1–5 of 28